Public limited company · Anderlecht · incorporated on 09/12/1991
| 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2007 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | 1,5 M € | -9.7% | 1,7 M € | +1.5% | 1,7 M € | +3.4% | 1,6 M € | +207.0% | 521,2 k € | -80.8% | 2,7 M € | +22.6% | 2,2 M € | +94.6% | 1,1 M € | — | — | — | — | ||||||||||
| Gross margin | 2,8 M € | -0.7% | 2,8 M € | +55.4% | 1,8 M € | +12.1% | 1,6 M € | +192.3% | 549,9 k € | — | — | — | — | — | — | — | 385,6 k € | +269.2% | -227,9 k € | -275.1% | 130,1 k € | +181.2% | -160,2 k € | -372.9% | 58,7 k € | |||||||||
| EBITDA | 2,7 M € | -0.1% | 2,8 M € | +53.0% | 1,8 M € | +130.3% | 780,7 k € | +219.5% | 244,3 k € | -69.1% | 790,8 k € | +53.2% | 516,2 k € | +17.3% | 440,2 k € | +312.7% | 106,7 k € | +119.2% | -556,6 k € | -138.8% | 1,4 M € | +10.8% | 1,3 M € | +500.1% | 215,8 k € | +179.0% | -273,0 k € | -388.9% | 94,5 k € | +158.8% | -160,6 k € | -378.0% | 57,8 k € | |
| Operating profit | 2,4 M € | +0.7% | 2,4 M € | +216.9% | 744,1 k € | +2323.5% | 30,7 k € | +105.1% | -603,7 k € | -352.7% | 238,9 k € | +166.5% | -359,5 k € | -10.6% | -325,1 k € | +53.4% | -698,0 k € | +42.7% | -1,2 M € | -251.3% | 804,4 k € | +8.7% | 740,3 k € | +385.5% | -259,3 k € | +60.4% | -655,2 k € | -37.9% | -475,3 k € | -9.3% | -434,7 k € | -852.3% | 57,8 k € | |
| Profit/loss | 3,0 M € | +5.9% | 2,9 M € | +203.4% | 939,7 k € | +1135.6% | 76,1 k € | +113.3% | -571,8 k € | -291.6% | 298,4 k € | +173.2% | -407,7 k € | +14.4% | -476,0 k € | +40.4% | -798,9 k € | +39.8% | -1,3 M € | -305.4% | 645,9 k € | -7.0% | 694,6 k € | +314.6% | -323,7 k € | +52.4% | -680,7 k € | -5.6% | -644,6 k € | -44.0% | -447,6 k € | -874.7% | 57,8 k € | |
| Equity | 11,7 M € | +34.8% | 8,7 M € | +49.0% | 5,8 M € | +19.3% | 4,9 M € | -22.0% | 6,2 M € | -8.4% | 6,8 M € | +4.6% | 6,5 M € | +238.2% | 1,9 M € | -19.8% | 2,4 M € | -24.9% | 3,2 M € | -29.3% | 4,5 M € | +615.0% | 633,5 k € | +1136.0% | -61,1 k € | -123.3% | 262,6 k € | -72.2% | 943,2 k € | -40.6% | 1,6 M € | +640.2% | 214,5 k € | |
| Total assets | 15,2 M € | +16.0% | 13,1 M € | +18.0% | 11,1 M € | +0.8% | 11,0 M € | +41.8% | 7,8 M € | -36.1% | 12,2 M € | +2.5% | 11,9 M € | +99.5% | 5,9 M € | +7.9% | 5,5 M € | +9.1% | 5,0 M € | -24.9% | 6,7 M € | +13.0% | 5,9 M € | +42.8% | 4,2 M € | +30.1% | 3,2 M € | +43.3% | 2,2 M € | -6.2% | 2,4 M € | +577.1% | 351,9 k € | |
| Cash | 48,6 k € | -24.6% | 64,5 k € | -37.9% | 103,9 k € | +82.8% | 56,8 k € | +284.9% | 14,8 k € | -34.7% | 22,6 k € | -64.2% | 63,1 k € | +72.3% | 36,6 k € | +85.5% | 19,7 k € | +1.9% | 19,4 k € | +192.0% | 6,6 k € | -77.1% | 29,0 k € | -32.7% | 43,1 k € | -34.0% | 65,3 k € | +491.6% | 11,0 k € | -97.2% | 401,0 k € | +313.4% | 97,0 k € | |
| Debts | 331,3 k € | -59.9% | 825,7 k € | -26.4% | 1,1 M € | -20.6% | 1,4 M € | -2.4% | 1,4 M € | -72.8% | 5,3 M € | +0.4% | 5,3 M € | +32.2% | 4,0 M € | +29.4% | 3,1 M € | +68.7% | 1,8 M € | -16.0% | 2,2 M € | -58.7% | 5,3 M € | +25.7% | 4,2 M € | +43.8% | 2,9 M € | +127.6% | 1,3 M € | +86.0% | 694,3 k € | +1794.3% | 36,6 k € | |
| Staff | — | — | — | — | 1 | 1 | 1,6 | 2 | 2 | 2 | 1,1 | 0,5 | 2 | 0,9 | 0,9 | — | — | |||||||||||||||||
Public limited company profitable and well capitalised. Cash position declining (-24.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
NEOGEN is a Public limited company incorporated in 1991. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Anderlecht.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette